Clincosm LogoSign in Get a demo

circulating tumor dna

Showing 1 - 25 of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rectal Cancer Patients Based on ctDNA-MRD Technology

Recruiting
  • Rectal Adenocarcinoma
  • +3 more
  • MRD detection
  • Guangzhou, Guangdong, China
    WeiWei Xiao
Jul 31, 2023

ctDNA Methylation for Epithelial Ovarian Cancer

Recruiting
  • Epithelial Ovarian Cancer
  • +7 more
  • CDO1 and HOXA9 methylation assay
  • Beijing, Beijing, China
    Lei Li
Mar 24, 2023

ctDNA Methylation for Detecting Ovarian Cancer

Recruiting
  • Epithelial Ovarian Cancer
  • +8 more
  • Methylation assay
  • Beijing, Beijing, China
    Lei Li
Mar 24, 2023

Circulating Tumor DNA in Colorectal Cancer Undergoing

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Circulating Tumor DNA
    • Besançon, France
    • +15 more
    Mar 24, 2023

    Locally Advanced Rectal Carcinoma, Circulating Tumor DNA Trial in Beijing (circulating tumor DNA)

    Recruiting
    • Locally Advanced Rectal Carcinoma
    • Circulating Tumor DNA
    • circulating tumor DNA
    • Beijing, Beijing, China
      Department of General Surgery, Peking Union Medical College Hosp
    Oct 27, 2022

    Lung Cancer, Non-small Cell, EGFR Gene Mutation, EGFR-TKI Resistant Mutation Trial in Changsha (Genomic profiles detection,

    Recruiting
    • Lung Cancer, Non-small Cell
    • +4 more
    • Genomic profiles detection
    • circulating tumor DNA detection
    • Changsha, Hunan, China
      Department of Oncology, The Second Xiangya Hospital, Central Sou
    Oct 25, 2022

    Testing Circulating Tumour DNA for Homologous Recombination Gene

    Recruiting
    • Circulating Tumor DNA
    • Metastatic Prostate Cancer
    • Blood sample
    • Urine sample
    • Tours, France
      University hospital
    Sep 6, 2022

    Advanced Colorectal Cancer, Circulating Tumor DNA Trial in Shanghai (Local treatment)

    Recruiting
    • Advanced Colorectal Cancer
    • Circulating Tumor DNA
    • Local treatment
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Aug 8, 2022

    Circulating Tumor DNA-Guided Late-Line Treatment in Late-Stage

    Completed
    • Metastatic Breast Cancer
    • +2 more
    • Control group
    • Case group
    • (no location specified)
    Jun 16, 2022

    Circulating Tumor DNA (ctDNA) in Late-stage Breast Cancer

    Completed
    • Metastatic Breast Cancer
    • +2 more
    • ctDNA testing
    • (no location specified)
    Jun 16, 2022

    Breast Cancer, Triple Negative Breast Cancer, Residual Cancer Trial in United States (Atezolizumab, Sacituzumab govitecan)

    Recruiting
    • Breast Cancer
    • +3 more
    • San Francisco, California
    • +8 more
    May 25, 2022

    Hepatocellular Carcinoma and Circulating Tumor DNA Monitoring of

    Recruiting
    • Circulating Tumor DNA
    • +2 more
    • DNA
    • Rouen, France
      CHU de Rouen
    May 23, 2022

    Non Small Cell Lung Cancer, Complete Surgical Resection, Circulating Tumor DNA Trial in Toronto (Nivolumab, Pemetrexed,

    Recruiting
    • Non Small Cell Lung Cancer
    • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Apr 21, 2022

    NSCLC, Non-Small-Cell Lung Carcinoma, Circulating Tumor DNA Trial (biological, drug, other)

    Withdrawn
    • Non-Small Cell Lung Cancer
    • +2 more
    • Nivolumab
    • +8 more
    • (no location specified)
    Mar 9, 2022

    Circulating Tumor DNA, Endometrial Cancer Trial in Poitiers (One arm only)

    Recruiting
    • Circulating Tumor DNA
    • Endometrial Cancer
    • One arm only
    • Poitiers, France
      CHU Poitiers, PRC
    Mar 4, 2022

    OPTImal PALliative Anti-epidermal Growth Factor Receptor

    Active, not recruiting
    • Colorectal Cancer Metastatic
    • +5 more
    • Plasma circulating DNA analysis
    • Aarhus, Denmark
      Aarhus University Hospital
    Feb 24, 2022

    Colorectal Cancer, Circulating Tumor DNA, Adjuvant Chemo Trial in Denmark (Capox (or FOLFOX) including flouropyrimidine and

    Recruiting
    • Colorectal Cancer
    • +3 more
    • Capox (or FOLFOX) including flouropyrimidine and oxaliplatin combination chemotherapy
    • Intensified Follow-up Schedule
    • Aalborg, Denmark
    • +3 more
    Feb 24, 2022

    Breast Cancer, Digestive Cancer, Gynecologic Cancer Trial in Poitiers (Blood samples)

    Recruiting
    • Breast Cancer
    • +4 more
    • Blood samples
    • Poitiers, France
      CHU POitiers
    Feb 14, 2022

    Colorectal Tumors, Trifluridine and Tipiracil, Circulating Tumor DNA Trial in Japan, Taiwan (trifluridine and tipiracil,

    Recruiting
    • Colorectal Neoplasms
    • +2 more
    • trifluridine and tipiracil
    • Placebo
    • Nagoya, Aichi, Japan
    • +38 more
    Jan 18, 2022

    NSCLC, Next-Generation Sequencing, Chemo, Adjuvant Trial in Xi'an (Adjuvants, Pharmaceutic)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +4 more
    • Adjuvants, Pharmaceutic
    • Xi'an, Baqiao, China
      The Second Affiliated The Second Affiliated Hospital of Air Forc
    Dec 9, 2021

    Stage III Colorectal Cancer, Circulating Tumor DNA Trial in Shanghai (ctDNA dynamic monitoring)

    Recruiting
    • Stage III Colorectal Cancer
    • Circulating Tumor DNA
    • ctDNA dynamic monitoring
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Dec 3, 2021

    Treatment Efficacy in Patients With Ovarian Cancer

    Not yet recruiting
    • High-grade Serous Ovarian Cancer
    • Circulating Tumor DNA
      • (no location specified)
      Aug 25, 2021

      Circulating Tumor DNA Trial in Shanghai (ct-DNA)

      Recruiting
      • Circulating Tumor DNA
      • ct-DNA
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Jul 13, 2021

      Non Small Cell Lung Cancer, Circulating Tumor Cell, Circulating Tumor DNA Trial in Copenhagen (PET/CT)

      Recruiting
      • Non Small Cell Lung Cancer
      • +2 more
      • PET/CT
      • Copenhagen, Denmark
      • +1 more
      Oct 6, 2020

      Pancreatic Cancer, Circulating Tumor DNA, KRAS Mutation-Related Tumors Trial (Blood samples)

      Completed
      • Pancreatic Cancer
      • +2 more
      • Blood samples
      • (no location specified)
      Sep 17, 2020